Elevated expression of retinoic acid receptor-α (RARα) in estrogen- receptor-positive breast carcinomas as detected by immunohistochemistry

Diagnostic Molecular Pathology

Volumn 6, Issue 1, 1997, Pages 42-48

  Han, Qi Xia ^a   Allegretto, Elizabeth A ^c   Shao, Zhi Ming ^a   Kute, Timothy E ^b   Ordonez, Jose ^a   Aisner, Seena C ^a   Rishi, Arun K ^a   Fontana, Joseph A ^a,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c LIGAND PHARMACEUTICALS INC   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

Breast carcinoma; Estradiol; Immunohistochemistry; Retinoic acid receptor

Indexed keywords

RETINOIC ACID RECEPTOR;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CELL GROWTH; CYTOMETRY; ESTRADIOL BLOOD LEVEL; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR BINDING; RECEPTOR UPREGULATION;

BREAST NEOPLASMS; CARCINOMA; HUMANS; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, RETINOIC ACID; TUMOR CELLS, CULTURED;

EID: 0031053539     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199702000-00007     Document Type: Article

References (39)

1. Apfel R, Benbrook D, Lernhardt E, et al. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol 1994;14:7025-35.
2. Baes M, Gulick T, Choi H-S, et al. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol 1994;14:1544-52.
3. Boylan JF, Lufkin T, Achkar CC, et al. Target disruption of retinoic acid receptor α (RARα) and RARγ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol Cell Biol 1995;15: 843-51.
4. Evans RM. The steroid and thyroid hormone receptor family. Science 1988;240:889-95.
5. Fontana JA. Interaction of retinoids and tamoxifen on the inhibition of human mammary cell proliferation. Exp Cell Biol 1987;55:136-44.
6. Fontana JA, Burrows A, Cooper BN, Miranda D. Retinoid modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells. Cancer Res 1990;50:1997-2002.
7. Fontana JA, Nervi C, Shao Z-M, Jetten AM. Retinoid antagonism of estrogen responsive transforming growth factor a and pS2 gene expression in breast carcinoma cells. Cancer Res 1992;52:3938-45.
8. Gudas LJ. Retinoids, retinoid-responsive genes, cell differentiation and cancer. Cell Growth Differ 1992;3:655-62.
9. Hermann T, Hoffman B, Zhang X-K, et al. Heterodimeric receptors complexes determine 3,5,3′-triiodothyronine and retinoid signalling specificities. Mol Endocrinol 1992;6:1153-62.
10. 3 signalling. Nature 1992;353:446-9.
11. Koga M, Sutherland RL. Retinoic acid acts synergistically with 1,25-dihydroxy vitamin D3 or antiestrogen to inhibit T47D human breast cancer cell proliferation. J Steroid Biochem Mol Biol 1991;39:455-60.
12. Kute TM, Muss HB, Cooper MR, et al. Use of flow cytometry for prognosis of state II adjuvant-treated breast cancer patients. Cancer 1990;66:1810-6.
13. Leid M, Kastner P, Lyons R, et al. Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind sequences efficiently. Cell 1992;68: 377-95.
14. Li XS, Shao Z-M, Sheikh M-S, et al. Retinoic acid nuclear receptor β (RARβ) inhibits breast carcinoma anchorage independent growth. J Cell Physiol 1995;165:449-58.
15. Li E, Sucov HM, Lee K-F, et al. Normal development and growth of mice carrying a targeted disruption of the α 1 retinoic acid receptor gene. Proc Natl Acad Sci USA 1993; 90:1590-4.
16. Lohnes D, Dierich A, Ghyselinck N, et al. Retinoid receptors and binding proteins. Cell Sci 1991;16(suppl):69-76.
17. Lohnes D, Kastner P, Dierich A, et al. Function of retinoic acid receptor γ in the mouse. Cell 1993;73:643-58.
18. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem Biophys Acta 1980; 608:33-91.
19. Lufkin T, Lohnes D, Mark M, et al. High postnatal lethality and testis degeneration in retinoic acid receptor a mutant mice. Proc Natl Acad Sci USA 1993;90:7225-9.
20. Marth C, Bock G, Daxenbichler G. Effects of 4-hydroxyphenyl retinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. J Natl Cancer Inst 1983;75:871-5.
21. Marth C, Bock G, Daxenbichler G. Effect of retinoic acid and 4-hydroxytamoxifen on human breast cancer cell lines. Biochem Pharmacol 1984;33:2217-21.
22. Moasser MM, DeBlasio A, Dmitrovsky E. Response and resistance to retinoic acid are mediated through the retinoic receptor γ in human teratocarcinomas Oncogene 1994;9: 833-40.
23. Moon RC, Mehta RG, Detriac CJ. Retinoids as chemopreventative agents for breast cancer. Cancer Det Prev 1992; 16:73-9.
24. Nagpal S, Athaninar J, Chandraratna RAS. Separation of transactivation and AP-1 antagonism functions of RARα. J Biol Chem 1995;270:923-7.
25. Nagpal S, Saunders M, Kastner P, et al. Promoter context and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 1992;70:1001-19.
26. O'Malley BW. The steroid superfamily, more excitement predicted for the future. Mol Endocrinol 1990;4:363-9.
27. Pfahl M. Nuclear/AP-1 interaction. Endocr Rev 1993;14: 651-8.
28. Roman SD, Clarke CL, Hall RE, et al. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res 1992;52:2236-42.
29. Roman SD, Ormandy CJ, Manning OL, et al. Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res 1993;53:5940-5.
30. Schule R, Rangarajan P, Yang N, et al. Retinoic acid is a negative regulator of AP-1 responsive genes. Proc Natl Acad Sci USA 1991;88:6092-6.
31. Shao ZM, Sheikh MS, Chen J-C, et al. Expression of the retinoic acid nuclear receptors (RARs) and retinoid X receptor (RXR) genes in estrogen receptor positive and negative breast cancer. Int J Oncol 1994;4:859-63.
32. Shao ZM, Sheikh MS, Ordonez JV, et al. IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma. Cancer Res 1992;52:5100-3.
33. Sheikh MS, Shao ZM, Chen J-C, et al. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RARa gene expression and sensitivity to growth inhibition by retinoic acid. J Cell Biochem 1993;53:394-404.
34. Sporn MB, Roberts AB. Interaction of retinoids and transforming growth factor-β in the regulation of cell differentiation and proliferation. Mol Endocrinol 1991;5:3-7.
35. Titcomb MW, Gottardis MM, Pike JW, Allegretto EA. Sensitive and specific detection of retinoid receptor subtype proteins in cultured cell and tumor extracts. Mol Endocrinol 1994;8:870-7.
36. Umesono K, Murakami KK, Thompson CC, Evans RM. Direct repeats as selective response elements for the thyroid hormone, retinoic acid and vitamin D3 receptors. Cell 1991; 65:1255-66.
37. Van der Burg B, van der Leede B-JM, Kwakkenbos-Isbrücker L, et al. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol 1993; 91:149-57.
38. Yu VC, Delsert C, Andersen B, et al. RXRβ, a coregulator that enhances binding of retinoic acid, thyroid hormone and vitamin D receptors to their cognate response elements. Cell 1991;67:1251-66.
39. Zhang X-K, Hoffman B, Tran P, et al. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 1992;355:441-6.